Throne has successfully secured $10 million in Series A funding to broaden its AI-driven diagnostic capabilities beyond gut health.
The funding will enable Throne to enhance its innovative toilet sensor, which utilizes computer vision to analyze bowel movements, providing valuable insights into gut health through an accompanying app. Originally launched in March, the device currently assesses aspects such as consistency and hydration, but the new investment is aimed at advancing features that could detect early signs of colon cancer through a conversational AI coach.
As the market for gut health is projected to reach $105 billion, Throne is positioning itself to cater to a diverse audience, including the 40% of individuals with gastrointestinal disorders. The company faces challenges related to privacy and stigma, but it is not alone; competitors like Withings and Kohler are also exploring how to transform personal health observations into clinically relevant data.
The rise of colorectal cancer among younger populations underscores the need for innovative screening solutions. Throne's approach reflects a growing trend in healthcare technology, where discreet, continuous monitoring could redefine how we approach diagnostics, much like wearable devices have done for fitness and health tracking.